Author Block: K. M. Chapagain, M. Rajeswari Amma, J. Clarke, C. Lowe, T. E. Kirkbride, S. Dahal, S. Gieseg, P. Butler, A. Butler; Christchurch/NZ
Purpose or Learning Objective: The purpose of this study was to evaluate water and lipid component measurement from spectral photon-counting CT for the detection of bone marrow oedema in acute bone injury.
Methods or Background: Patients with acute bone injury were imaged using high-resolution spectral photon-counting CT in the early phase of injury. Physical phantoms were developed to mimic bone marrow and validate water and lipid measurements. The phantoms contained a two-material mixture (water gel, peanut oil) and a three material mixture (water gel, oil and hydroxyapatite nanopowder). Lipid and water maps were generated by harnessing the spectral information contained in the photon-counting CT images. For both phantoms and human images, regions of interest (ROIs) were drawn in the target areas and reference areas to quantitatively measure the water and lipid concentrations. The estimated values from the photon-counting CT were compared with reference values using linearity plots, and the agreement between reference and estimated values were analysed with Bland-Altman plots.
Results or Findings: Estimated water and lipid mass density values had a linear correlation with reference values (linearity=0.98, 0.99) The measurements were not significantly different from reference values (p=0.63, 0.91) with average quantification errors (Bias) (-1.9% and -0.4%), upper limit of agreement (11.5%, 8.7%), and lower limit of agreement (-14.7%, -7.9%) for water and lipid component estimation respectively. Similar to phantom results, the targeted regions in human images showed an increase in water mass density.
Conclusion: Lipid and water components measured from the system are validated using phantom measurements to demonstrate the bone marrow oedema in patients with an acute injury.
Limitations: Comparisons with MRI is not done at this stage, which will be performed in the next phase.
Ethics committee approval: The ethics committee approval was received (18/STH/221).
Funding for this study: This study is funded by MBIE, New Zealand.